Details of the Drug Formulations

General Information of Drug (ID: DMGZQEF)

• Drug Name: Mifepristone Drug Info
• Synonyms: Mifedren; HRA-052015; Mifepristone (Cushing's disease); ACTH modulator (Cushing's disease), HRA; Adrenocorticotropic hormone modulator (Cushing's disease), HRA Pharma; Mifepristone (Cushing's disease), HRA pharma

Indication

Disease Entry	ICD 11	Status	REF
Cushing disease	5A70	Approved	[1]

• Cross-matching ID:
  PubChem CID: 55245
  ChEBI ID: CHEBI:50692
  CAS Number: 84371-65-3
  TTD ID: D0Z4EI
  VARIDT ID: DR00714
  INTEDE ID: DR1091
  ACDINA ID: D00432

Full List of Drug Formulations Containing This Drug

Mifepristone 300 mg tablet

Company	Formulation ID	FDA Description
Corcept Therapeutics	F14056	Sodium lauryl sulfate; D&c yellow no. 10; Fd&c yellow no. 6; Magnesium stearate; Titanium dioxide; Triacetin; Polysorbate 80; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Sodium starch glycolate type a potato

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2805).